Standout Papers
Citation Impact
Citing Papers
A Tlr7 translocation accelerates systemic autoimmunity in murine lupus
2006
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology.
1999
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low
2000
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
Localization of Tumor Necrosis Factor α in Synovial Tissues and at the Cartilage–Pannus Junction in Patients With Rheumatoid Arthritis
1991
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer
2008
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
2001 Standout
The Complex Immunology of Human Coccidioidomycosis
2007
Impaired immune and acute-phase responses in interleukin-6-deficient mice
1994 StandoutNatureNobel
Signal transduction and transcription factors in rheumatic disease
1999
Inflammation and cancer
2002 StandoutNature
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
2006 StandoutNature
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
Even though T-cell-directed trials have been of limited success, is there reason for optimism?
2006
Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium
2000
Coccidioidomycosis in Rheumatology Patients
2007
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Coccidioidomycosis in Liver Transplant Recipients in an Endemic Area
2010
Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
2008
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
2005
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab
2004
Tai Chi Improves Pain and Functional Status in Adults with Rheumatoid Arthritis: Results of a Pilot Single-Blinded Randomized Controlled Trial
2008
Dendritic cells: versatile controllers of the immune system
2007 StandoutNobel
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Pattern Recognition Receptors and Inflammation
2010 Standout
Monoclonal expansion of synoviocytes in rheumatoid arthritis
1998
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics
2013
Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease
2002
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Rheumatoid Arthritis
1990
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice
2003 StandoutNatureNobel
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
1994 StandoutNature
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus.
1997
Management of coccidioidomycosis in patients receiving biologic response modifiers or disease‐modifying antirheumatic drugs
2012
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Inflammatory Bowel Disease
2002 Standout
Systemic Lupus Erythematosus
2011 Standout
Delineating the Genetic Basis of Systemic Lupus Erythematosus
2001
Tai Chi is effective in treating knee osteoarthritis: A randomized controlled trial
2009
Refractory Disseminated Coccidioidomycosis and Mycobacteriosis in Interferon‐γ Receptor 1 Deficiency
2009
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
1998
Atherosclerosis — An Inflammatory Disease
1999 Standout
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.
1992
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Coccidioidomycosis-associated Deaths, United States, 1990–2008
2012
Genetic dissection of systemic lupus erythematosus
1999
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
A paradigm for the evaluation and management of spinal coccidioidomycosis
2015
A Randomized Trial of Tai Chi for Fibromyalgia
2010 Standout
Expressed Murine and Human CDR-H3 Intervals of Equal Length Exhibit Distinct Repertoires that Differ in their Amino Acid Composition and Predicted Range of Structures
2003
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
Pericytes regulate the blood–brain barrier
2010 StandoutNature
Susceptibility genes in the pathogenesis of murine lupus.
2002
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
2004
Cancer-related inflammation
2008 StandoutNature
Spontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific Epistasis
2000
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
1999 StandoutNature
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Pathogen Recognition and Innate Immunity
2006 Standout
Sympathetic Neural Mechanisms of Cyclosporine-Induced Hypertension*
1996
Lupus Glomerulonephritis Revisited 2004: Autoimmunity and End‐Organ Damage
2004
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
2010
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
Evidence for the Effects of a Superantigen in Rheumatoid Arthritis
1991 Science
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner
2004
Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for Akt1
2011 StandoutNobel
Activation and differentiation requirements of primary T cells in vitro.
1993 StandoutNobel
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
1997 StandoutNobel
Role of TLR9 in Anti-Nucleosome and Anti-DNA Antibody Production in lpr Mutation-Induced Murine Lupus
2006
Regional analysis ofp53mutations in rheumatoid arthritis synovium
2002
Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop
2005 Standout
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
1991
Nucleosome-Specific Regulatory T Cells Engineered by Triple Gene Transfer Suppress a Systemic Autoimmune Disease
2004
In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.
1992
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 StandoutNobel
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
2001 StandoutNobel
Chimeric tumor necrosis factor receptors with constitutive signaling activity.
1995 StandoutNobel
A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease
2003 StandoutNobel
Microsatellite Instability and Suppressed DNA Repair Enzyme Expression in Rheumatoid Arthritis
2003
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.
1992
Microarray analysis of blood microvessels from PDGF‐B and PDGF‐Rβ mutant mice identifies novel markers for brain pericytes
2006
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
2006 StandoutScienceNobel
Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene.
1998
Recent Advances in Our Understanding of the Environmental, Epidemiological, Immunological, and Clinical Dimensions of Coccidioidomycosis
2013
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia
2003 Nobel
Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium
1997
Interleukin-6 and Its Receptor: A Paradigm for Cytokines
1992 Science
Works of David E. Yocum being referenced
The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo‐controlled trial
2006
Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty‐eight weeks. An open‐label extension study
1997
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Expression of PTHrP and its cognate receptor in the rheumatoid synovial microcirculation
2002
Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis
1995
Anin vitro model for studying mechanisms underlying synoviocyte-mediated cartilage invasion in rheumatoid arthritis
1996
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists
2004
Cyclosporin A in Severe, Treatment-Refractory Rheumatoid Arthritis
1988
Characteristics of tumor necrosis factor production in rheumatoid arthritis
1989
Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody campath‐1h administered by daily subcutaneous injection
1995
Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids.
1989
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: A randomized, double-blind six-week trial with eighteen-week extension
1999
Specificity mapping of human anti‐T cell receptor monoclonal natural antibodies: defining the properties of epitope recognition promiscuity
2002
EXERCISE, EDUCATION, AND BEHAVIORAL MODIFICATION AS ALTERNATIVE THERAPY FOR PAIN AND STRESS IN RHEUMATIC DISEASE
2000
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis.
2002
Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis.
1998
US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis.
1999